The capsaicin analog nonivamide decreases total energy intake from a standardized breakfast and enhances plasma serotonin levels in moderately overweight men after administered in an oral glucose tolerance test: A randomized, crossover trial

Molecular Nutrition and Food Research

Volumn 58, Issue 6, 2014, Pages 1282-1290

  Hochkogler, Christina M ^a   Rohm, Barbara ^a   Hojdar, Karin ^a   Pignitter, Marc ^a   Widder, Sabine ^b   Ley, Jakob P ^b   Krammer, Gerhard E ^b   Somoza, Veronika ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b SYMRISE AG   (Germany)

Author keywords

Capsaicin; Human intervention study; Nonivamide; Satiety; Total energy intake

Indexed keywords

CAPSAICIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE BLOOD LEVEL; INSULIN; NONIVAMIDE; PEPTIDE FRAGMENT; PEPTIDE YY; PEPTIDE YY [3-36]; SEROTONIN;

ADULT; ANALOGS AND DERIVATIVES; APPETITE; BLOOD; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HUNGER; MALE; MEAL; OBESITY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; APPETITE; BLOOD GLUCOSE; BODY MASS INDEX; BREAKFAST; CAPSAICIN; CROSS-OVER STUDIES; ENERGY INTAKE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; HUNGER; INSULIN; MALE; OVERWEIGHT; PEPTIDE FRAGMENTS; PEPTIDE YY; SEROTONIN; YOUNG ADULT;

EID: 84901913224     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300821     Document Type: Article

References (42)

1. Louie, S. M., Roberts, L. S., Nomura, D. K., Mechanisms linking obesity and cancer. Biochim. Biophys. Acta 2013, 1831, 1499-1508.
2. Penn, L., White, M., Lindstrom, J., den Boer, A. T. et al., Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PloS One 2013, 8, e57143.
3. Sierra-Johnson, J., Romero-Corral, A., Somers, V. K., Lopez-Jimenez, F. et al., Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur. J. Cardiovasc. Prev. Rehabil. 2008, 15, 336-340.
4. Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E. et al., Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003, 42, 878-884.
5. Van Kleef, E., Van Trijp, J. C., Van Den Borne, J. J., Zondervan, C., Successful development of satiety enhancing food products: towards a multidisciplinary agenda of research challenges. Crit. Rev. Food Sci. Nutr. 2012, 52, 611-628.
6. Yoshioka, M., St-Pierre, S., Drapeau, V., Dionne, I. et al., Effects of red pepper on appetite and energy intake. Br. J. Nutr. 1999, 82, 115-123.
7. Westerterp-Plantenga, M. S., Smeets, A., Lejeune, M. P., Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int. J. Obes. 2005, 29, 682-688.
8. Tzavara, E. T., Li, D. L., Moutsimilli, L., Bisogno, T. et al., Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications. Biol. Psychiatry 2006, 59, 508-515.
9. Reinbach, H. C., Smeets, A., Martinussen, T., Moller, P. et al., Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance. Clin. Nutr. 2009, 28, 260-265.
10. Nelson, E. K., Vanillyl-acyl amides. J. Am. Chem. Soc. 1919, 41, 2121-2130.
11. Haas, J. S., Whipple, R. E., Grant, P. M., Andresen, B. D. et al., Chemical and elemental comparison of two formulations of oleoresin capsicum. Sci. Justice 1997, 37, 15-24.
12. Reilly, C. A., Crouch, D. J., Yost, G. S., Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray products. J. Forensic Sci. 2001, 46, 502-509.
13. Constant, H. L., Cordell, G. A., West, D. P., Nonivamide, a constituent of capsicum oleoresin. J. Nat. Prod. 1996, 59, 425-426.
14. Rohm, B., Holik, A. K., Somoza, M. M., Pignitter, M. et al., Nonivamide, a capsaicin analog, increases dopamine and serotonin release in SH-SY5Y cells via a TRPV1-independent pathway. Mol. Nutr. Food Res. 2013, 57, 2008-2018.
15. Bellisle, F., Drewnowski, A., Anderson, G. H., Westerterp-Plantenga, M. et al., Sweetness, satiation, and satiety. J. Nutr. 2012, 142, 1149S-1154S.
16. Halford, J. C., Harrold, J. A., Lawton, C. L., Blundell, J. E., Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr. Drug Targets 2005, 6, 201-213.
17. Erlanson-Albertsson, C., How palatable food disrupts appetite regulation. Basic. Clin. Pharmacol. Toxicol. 2005, 97, 61-73.
18. Naslund, E., Hellstrom, P. M., Appetite signaling: from gut peptides and enteric nerves to brain. Physiol. Behav. 2007, 92, 256-262.
19. DeSoto, M. C., Geary, D. C., Hoard, M. K., Sheldon, M. S. et al., Estrogen fluctuations, oral contraceptives and borderline personality. Psychoneuroendocrino. 2003, 28, 751-766.
20. Morgan, J. F., Reid, F., Lacey, J. H., The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ 1999, 319, 1467-1468.
21. Reilly, C. A., Ehlhardt, W. J., Jackson, D. A., Kulanthaivel, P. et al., Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chem. Res. Toxicol. 2003, 16, 336-349.
22. Brand, T., Anderson, G. M., The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin. Chem. 2011, 57, 1376-1386.
23. Ludy, M. J., Mattes, R. D., The effects of hedonically acceptable red pepper doses on thermogenesis and appetite. Physiol. Behav. 2011, 102, 251-258.
24. Stubbs, R. J., Hughes, D. A., Johnstone, A. M., Rowley, E. et al., The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br. J. Nutr. 2000, 84, 405-415.
25. Rodearmel, S. J., Wyatt, H. R., Barry, M. J., Dong, F. et al., A family-based approach to preventing excessive weight gain. Obesity 2006, 14, 1392-1401.
26. Degen, L., Oesch, S., Casanova, M., Graf, S. et al., Effect of peptide YY3-36 on food intake in humans. Gastroenterology 2005, 129, 1430-1436.
27. Naslund, E., Barkeling, B., King, N., Gutniak, M. et al., Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int. J. Obes. Relat. Metab. Disord. 1999, 23, 304-311.
28. EFSA, Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations. EFSA J. 2012, 10, 2604(1-11).
29. Smeets, A. J., Westerterp-Plantenga, M. S., The acute effects of a lunch containing capsaicin on energy and substrate utilisation, hormones, and satiety. Eur. J. Nutr. 2009, 48, 229-234.
30. Mayer, J., Regulation of energy intake and the body weight: the glucostatic theory and the lipostatic hypothesis. Ann. N.Y. Acad. Sci. 1955, 63, 15-43.
31. Meguid, M. M., Fetissov, S. O., Varma, M., Sato, T. et al., Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000, 16, 843-857.
32. Lam, D. D., Heisler, L. K., Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes. Expert. Rev. Mol. Med. 2007, 9, 1-24.
33. Hoyer, D., Hannon, J. P., Martin, G. R., Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71, 533-554.
34. Heal, D. J., Gosden, J., Smith, S. L., A review of late-stage CNS drug candidates for the treatment of obesity. Int. J. Obes. 2013, 37, 107-117.
35. Lam, D. D., Garfield, A. S., Marston, O. J., Shaw, J. et al., Brain serotonin system in the coordination of food intake and body weight. Pharmacol. Biochem. Behav. 2010, 97, 84-91.
36. Berger, M., Gray, J. A., Roth, B. L., The expanded biology of serotonin. Annu. Rev. Med. 2009, 60, 355-366.
37. Wang, G. D., Wang, X. Y., Zou, F., Qu, M. et al., Mast cell expression of the serotonin1A receptor in guinea pig and human intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304, G855-G863.
38. Iceta, R., Mesonero, J. E., Aramayona, J. J., Alcalde, A. I., Expression of 5-HT1A and 5-HT7 receptors in Caco-2 cells and their role in the regulation of serotonin transporter activity. J. Physiol. Pharmacol. 2009, 60, 157-164.
39. Hillsley, K., Grundy, D., Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents. Neurosci. Lett. 1998, 255, 63-66.
40. Mazda, T., Yamamoto, H., Fujimura, M., Fujimiya, M., Gastric distension-induced release of 5-HT stimulates c-fos expression in specific brain nuclei via 5-HT3 receptors in conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287, G228-G235.
41. Daly, D. M., Park, S. J., Valinsky, W. C., Beyak, M. J., Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J. Physiol. 2011, 589, 2857-2870.
42. Chaiyasit, K., Khovidhunkit, W., Wittayalertpanya, S., Pharmacokinetic and the effect of capsaicin in capsicum frutescens on decreasing plasma glucose level. J. Med. Assoc. Thai. 2009, 92, 108-113.